TGFBR2 and colorectal carcinoma: The neoplasm showed high expression levels of LGR5 (stem cell marker gene, investigated as a therapeutic target in CRC) [65], FN1 (extracellular matrix remodeling) [66], and TGFBR2 (conditional tumor suppressor/activator as part of TGF signaling) [67].